127 related articles for article (PubMed ID: 11165100)
1. Physicochemical and biopharmaceutical characterization of BTA-243, a diacidic drug with low oral bioavailability.
Brown JR; Collett JH; Attwood D; Ley RW; Sims EE
Int J Pharm; 2001 Feb; 213(1-2):127-34. PubMed ID: 11165100
[TBL] [Abstract][Full Text] [Related]
2. Influence of monocaprin on the permeability of a diacidic drug BTA-243 across Caco-2 cell monolayers and everted gut sacs.
Brown JR; Collett JH; Attwood D; Ley RW; Sims EE
Int J Pharm; 2002 Oct; 245(1-2):133-42. PubMed ID: 12270250
[TBL] [Abstract][Full Text] [Related]
3. Effects of structural modifications on the intestinal permeability of angiotensin II receptor antagonists and the correlation of in vitro, in situ, and in vivo absorption.
Ribadeneira MD; Aungst BJ; Eyermann CJ; Huang SM
Pharm Res; 1996 Feb; 13(2):227-33. PubMed ID: 8932441
[TBL] [Abstract][Full Text] [Related]
4. In vitro solubility, dissolution and permeability studies combined with semi-mechanistic modeling to investigate the intestinal absorption of desvenlafaxine from an immediate- and extended release formulation.
Franek F; Jarlfors A; Larsen F; Holm P; Steffansen B
Eur J Pharm Sci; 2015 Sep; 77():303-13. PubMed ID: 26091569
[TBL] [Abstract][Full Text] [Related]
5. Prodrug approach for alphaIIbbeta3-peptidomimetic antagonists to enhance their transport in monolayers of a human intestinal cell line (Caco-2): comparison of in vitro and in vivo data.
Kamm W; Raddatz P; Gante J; Kissel T
Pharm Res; 1999 Oct; 16(10):1527-33. PubMed ID: 10554093
[TBL] [Abstract][Full Text] [Related]
6. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
7. Analysis of five active ingredients of Er-Zhi-Wan, a traditional Chinese medicine water-honeyed pill, using the biopharmaceutics classification system.
Cao X; Li H; Wang M; Ren X; Deng Y
Biomed Chromatogr; 2020 Feb; 34(2):e4757. PubMed ID: 31755125
[TBL] [Abstract][Full Text] [Related]
8. Epithelial transport of noscapine across cell monolayer and influence of absorption enhancers on in vitro permeation and bioavailability: implications for intestinal absorption.
Chougule MB; Patel AR; Patlolla R; Jackson T; Singh M
J Drug Target; 2014 Jul; 22(6):498-508. PubMed ID: 24731057
[TBL] [Abstract][Full Text] [Related]
9. Passive diffusion of weak organic electrolytes across Caco-2 cell monolayers: uncoupling the contributions of hydrodynamic, transcellular, and paracellular barriers.
Adson A; Burton PS; Raub TJ; Barsuhn CL; Audus KL; Ho NF
J Pharm Sci; 1995 Oct; 84(10):1197-204. PubMed ID: 8801334
[TBL] [Abstract][Full Text] [Related]
10. Preformulation study of etoposide: identification of physicochemical characteristics responsible for the low and erratic oral bioavailability of etoposide.
Shah JC; Chen JR; Chow D
Pharm Res; 1989 May; 6(5):408-12. PubMed ID: 2748532
[TBL] [Abstract][Full Text] [Related]
11. In Vitro and In Situ Characterization of Triterpene Glycosides From Cimicifuga racemosa Extract.
Disch L; Forsch K; Siewert B; Drewe J; Fricker G
J Pharm Sci; 2017 Dec; 106(12):3642-3650. PubMed ID: 28827038
[TBL] [Abstract][Full Text] [Related]
12. Intestinal permeability study of minoxidil: assessment of minoxidil as a high permeability reference drug for biopharmaceutics classification.
Ozawa M; Tsume Y; Zur M; Dahan A; Amidon GL
Mol Pharm; 2015 Jan; 12(1):204-11. PubMed ID: 25423288
[TBL] [Abstract][Full Text] [Related]
13. Study on biopharmaceutics classification and oral bioavailability of a novel multikinase inhibitor NCE for cancer therapy.
Yang Y; Fan CM; He X; Ren K; Zhang JK; He YJ; Yu LT; Zhao YL; Gong CY; Zheng Y; Song XR; Zeng J
Int J Mol Sci; 2014 Apr; 15(5):7199-212. PubMed ID: 24776763
[TBL] [Abstract][Full Text] [Related]
14. pH-dependent functional activity of P-glycoprotein in limiting intestinal absorption of protic drugs: kinetic analysis of quinidine efflux in situ.
Varma MV; Panchagnula R
J Pharm Sci; 2005 Dec; 94(12):2632-43. PubMed ID: 16258992
[TBL] [Abstract][Full Text] [Related]
15. Physicochemical profiling (solubility, permeability and charge state).
Avdeef A
Curr Top Med Chem; 2001 Sep; 1(4):277-351. PubMed ID: 11899112
[TBL] [Abstract][Full Text] [Related]
16. Biopharmaceutical and pharmacokinetic characterization of asiatic acid in Centella asiatica as determined by a sensitive and robust HPLC-MS method.
Yuan Y; Zhang H; Sun F; Sun S; Zhu Z; Chai Y
J Ethnopharmacol; 2015 Apr; 163():31-8. PubMed ID: 25596352
[TBL] [Abstract][Full Text] [Related]
17. Biopharmaceutics classification of selected beta-blockers: solubility and permeability class membership.
Yang Y; Faustino PJ; Volpe DA; Ellison CD; Lyon RC; Yu LX
Mol Pharm; 2007; 4(4):608-14. PubMed ID: 17637014
[TBL] [Abstract][Full Text] [Related]
18. Effect of the biologically active fragment of zonula occludens toxin, delta G, on the intestinal paracellular transport and oral absorption of mannitol.
Salama NN; Fasano A; Lu R; Eddington ND
Int J Pharm; 2003 Jan; 251(1-2):113-21. PubMed ID: 12527181
[TBL] [Abstract][Full Text] [Related]
19. [Mechanism of oral absorption of panaxnotoginseng saponins].
Han M; Han LM; Wang QS; Bai ZH; Fang XL
Yao Xue Xue Bao; 2006 Jun; 41(6):498-505. PubMed ID: 16927822
[TBL] [Abstract][Full Text] [Related]
20. Intestinal absorption mechanism of mirabegron, a potent and selective β₃-adrenoceptor agonist: involvement of human efflux and/or influx transport systems.
Takusagawa S; Ushigome F; Nemoto H; Takahashi Y; Li Q; Kerbusch V; Miyashita A; Iwatsubo T; Usui T
Mol Pharm; 2013 May; 10(5):1783-94. PubMed ID: 23560393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
